Introduction:
MilliporeSigma the Life Science business of Merck KGaA, Darmstadt Germany, has recently revealed plans to expand its facility in Lenexa, Kansas.
Features:
The expansion will involve the addition of 98,000 square feet of lab space and production capability specifically for manufacturing cell culture media.
An investment in the Kansas City area is expected to generate 60 job opportunities, contributing to increased employment in the region.
With this expansion, the Lenexa facility will become the largest dry powder cell culture media facility and Center of Excellence in North America for MilliporeSigma.
The investment reflects the company's dedication to meeting the evolving needs of customers worldwide and aligns with its growth plans.
The expanded production capacity will cater to current demand while ensuring a robust supply chain to meet future demand surges.
The addition of the new production line is a significant achievement, as the Lenexa site was originally designed to accommodate three manufacturing lines for dry powder cell culture media.
The expansion enables increased flexibility and faster manufacturing of cell culture media to better serve customers.
MilliporeSigma operates three Centers of Excellence for dry powder cell culture media manufacturing: Lenexa (serving the Americas), Nantong (Asia Pacific), and Irvine (Europe, Middle East, and Africa).
Specifications:
Name: MilliporeSigma
Type: Expansion
